Will cheap financials get even cheaper?

SPECIALIST

clock • 2 min read

Barely 12 months ago the notion of actively investing in financials was perceived as only for the adventurous. Even so, selling off a stock like HSBC was probably considered a step too far.

Since then, global financials – which are the world’s largest investment sector – have moved on, with the sector materially out-performing world markets over the past 12 months. Now many investors are wondering if they are willing to take more pain by sitting on the sidelines. It seems an opportune moment to avoid the scramble and buy whilst global financials remain fundamentally cheap. The key issue driving the sector has less to do with the froth provided by low interest rates, although that has helped, but more to do with the real improvement in capital positions on the back of recove...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot